Addressing missing data in clinical trials.
The reliability and interpretability of results from clinical trials can be substantially reduced by missing data. Frequently used approaches to address these concerns, such as upward adjustments in sample sizes or simplistic methods for handling missing data, including last-observation-carried-forward, complete-case, or worst-case analyses, are usually inadequate. Although rational imputation methods may be useful to treat missingness after it has occurred, these methods depend on untestable assumptions. Thus, the preferred and often only satisfactory approach to addressing missing data is to prevent it. Procedures should be in place to maximize the likelihood that outcome data will be obtained at scheduled times of evaluation for all surviving patients who have not withdrawn consent. To meaningfully reduce missing data, it is important to recognize and address many factors that commonly lead to higher levels of missingness.
University of Washington, Seattle, 98195-7232, USA. tfleming@u.washington.edu
Thomas R
TR
Fleming
D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000592:standards* / Q000706:statistics & numerical data*; D003627:Data Interpretation, Statistical; D006801:Humans; D007258:Informed Consent / Q000592:standards; D010352:Patient Dropouts; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards
Neuropsychopharmacology. 1992 Jan;6(1):39-48; discussion 49-63
1571068
BMJ. 2010 Mar 23;340:c332
20332509
JAMA. 2007 Feb 28;297(8):820-30
17327524
Lancet. 1999 Sep 4;354(9181):795-802
10485720
Account Res. 2006 Oct-Dec;13(4):285-309
17849641
Arch Gen Psychiatry. 2003 May;60(5):481-9
12742869
J Clin Oncol. 2009 Jun 10;27(17):2874-80
19414672
Lancet. 2003 Sep 13;362(9387):859-68
13678973
N Engl J Med. 2008 Sep 25;359(13):1400-2
18768938
N Engl J Med. 2005 Nov 17;353(20):2148-57
16291984
Stat Med. 2002 Oct 15;21(19):2959-70
12325112
Eur J Heart Fail. 2004 Jan;6(1):1-2
15012911
Br J Cancer. 1977 Jan;35(1):1-39
831755
J Biopharm Stat. 2009 Nov;19(6):957-68
20183458
Control Clin Trials. 2000 Jun;21(3):167-89
10822117